Composition of the gut microbiome, role of diet, lifestyle, and antioxidant therapies in diabetes mellitus and diabetic retinopathy

被引:2
作者
Oganov, Anthony C. [1 ]
Seddon, Ian [2 ]
Zein, Mike [3 ]
Yazdanpanah, Ghasem [4 ]
Fonoudi, Hossein [5 ,6 ]
Jabbehdari, Sayena [7 ]
机构
[1] Renaissance Sch Med, Dept Ophthalmol, Stony Brook, NY USA
[2] Nova Southeastern Univ, Coll Osteopath Med, Ft Lauderdale, FL USA
[3] Dept Ophthalmol, Cook Cty Hlth, Chicago, IL USA
[4] Univ Illinois, Illinois Eye & Ear Infirm, Dept Ophthalmol & Visual Sci, Chicago, IL USA
[5] Univ Tehran Med Sci, Farabi Eye Hosp, Eye Res Ctr, Tehran, Iran
[6] Iranshahr Univ Med Sci, Iranshahr, Iran
[7] Univ Arkansas Med Sci, Jones Eye Inst, Little Rock, AR 72205 USA
关键词
Microbiome; gut; diabetes; diabetic retinopathy; oxidative stress; antioxidant therapies; GLYCATION END-PRODUCTS; CHAIN FATTY-ACIDS; METFORMIN INHIBITS DEVELOPMENT; SULFATE-REDUCING BACTERIA; MEDITERRANEAN DIET; INSULIN-RESISTANCE; METABOLIC SIGNATURE; OXIDATIVE STRESS; PROTEIN; COMPLICATIONS;
D O I
10.1177/11206721231174490
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The gut microbiome is a complex ecosystem in the gastrointestinal tract composed of trillions of bacteria, viruses, fungi, and protozoa. Disruption of this delicate ecosystem, formally called "dysbiosis", has been linked to a variety of metabolic and inflammatory pathologies. Several studies have focused on abnormal microbiome composition and correlated these findings with the development of type 2 diabetes mellitus (T2DM) and diabetic retinopathy (DR). However, given the complexity of this ecosystem, the current studies are narrow in design and present variable findings. Composition of the gut microbiome in patients with DR significantly differs from patients with diabetes without retinopathy as well as from healthy controls. Additionally, the gut microbiome has been shown to modify effects of medication, diet, exercise, and antioxidant use on the development and progression of DR. In this paper, we present a comprehensive review of literature on the effect of oxidative stress, antioxidant therapies, and dysbiosis on DR.
引用
收藏
页码:367 / 383
页数:17
相关论文
共 130 条
[1]   Gut microbiota: A potential therapeutic target for management of diabetic retinopathy? [J].
Alarcon Yempen, Rosa Elvira ;
Venzel, Raphaelly ;
Paulino Campos, Maria Clara ;
de Oliveira, Larissa Pessoa ;
Dan Lins, Rodrigo Vasquez ;
Pessoni, Andre Moreira ;
Fanaro, Gustavo Bernardes ;
Souza, Anderson de Oliveira ;
Calaza, Karin da Costa ;
de Brito Alves, Jose Luiz ;
Cavalcanti-Neto, Marinaldo Pacifico .
LIFE SCIENCES, 2021, 286
[2]   Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy [J].
Alfonso-Munoz, Enrique Antonio ;
Burggraaf-sanchez de las Matas, Raquel ;
Mataix Boronat, Jorge ;
Molina Martin, Julio Cesar ;
Desco, Carmen .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
[3]   RETRACTED: Protective effect of metformin on rat diabetic retinopathy involves suppression of toll-like receptor 4/nuclear factor-k B expression and glutamate excitotoxicity (Retracted article. See vol. 157, 2025) [J].
Alomar, Suliman Y. ;
Barakat, Bassant M. ;
Eldosoky, Mohamed ;
Atef, Hoda ;
Mohamed, Abdelaty Shawky ;
Elhawary, Reda ;
El-Shafey, Mohamed ;
Youssef, Amal M. ;
Elkazaz, Amany Y. ;
Gabr, Attia M. ;
Elaskary, Abdelhakeem A. ;
Salih, Mohamed A. K. ;
Alolayan, Sultan Othman ;
Zaitone, Sawsan A. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90
[4]   The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration [J].
Altmann, Christine ;
Schmidt, Mirko H. H. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
[5]   Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature [J].
Amin, Shivam, V ;
Khanna, Saira ;
Parvar, Seyedeh P. ;
Shaw, Lincoln T. ;
Dao, David ;
Hariprasad, Seenu M. ;
Skondra, Dimitra .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (04) :317-329
[6]  
[Anonymous], 1981, Invest Ophthalmol Vis Sci, V21, P1
[7]   Effect of redox status of peripheral blood on immune signature of circulating regulatory and cytotoxic T cells in streptozotocin induced rodent model of type I diabetes [J].
Anupam, Kumari ;
Kaushal, Jyotsana ;
Prabhakar, Nirmal ;
Bhatnagar, Archana .
IMMUNOBIOLOGY, 2018, 223 (10) :586-597
[8]   Enterotypes of the human gut microbiome [J].
Arumugam, Manimozhiyan ;
Raes, Jeroen ;
Pelletier, Eric ;
Le Paslier, Denis ;
Yamada, Takuji ;
Mende, Daniel R. ;
Fernandes, Gabriel R. ;
Tap, Julien ;
Bruls, Thomas ;
Batto, Jean-Michel ;
Bertalan, Marcelo ;
Borruel, Natalia ;
Casellas, Francesc ;
Fernandez, Leyden ;
Gautier, Laurent ;
Hansen, Torben ;
Hattori, Masahira ;
Hayashi, Tetsuya ;
Kleerebezem, Michiel ;
Kurokawa, Ken ;
Leclerc, Marion ;
Levenez, Florence ;
Manichanh, Chaysavanh ;
Nielsen, H. Bjorn ;
Nielsen, Trine ;
Pons, Nicolas ;
Poulain, Julie ;
Qin, Junjie ;
Sicheritz-Ponten, Thomas ;
Tims, Sebastian ;
Torrents, David ;
Ugarte, Edgardo ;
Zoetendal, Erwin G. ;
Wang, Jun ;
Guarner, Francisco ;
Pedersen, Oluf ;
de Vos, Willem M. ;
Brunak, Soren ;
Dore, Joel ;
Weissenbach, Jean ;
Ehrlich, S. Dusko ;
Bork, Peer .
NATURE, 2011, 473 (7346) :174-180
[9]   ARTERIOLAR INVOLVEMENT IN DIABETIC RETINOPATHY [J].
ASHTON, N .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1953, 37 (05) :282-292
[10]   VASCULAR BASEMENT-MEMBRANE CHANGES IN DIABETIC-RETINOPATHY - MONTGOMERY LECTURE, 1973 [J].
ASHTON, N .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1974, 58 (04) :344-366